Johnson & Johnson Sees $1.1 Million Bearish Put Contract as Stock Trades Near 52-Week Highs
By TrendSpider Editor
A single unusual options contract worth $1,105,500 in premium has surfaced in Johnson & Johnson, pointing to a notable bearish directional bet as JNJ shares trade at $231.02. The contract, a put struck at $230 expiring in June 2027, was placed with 550 contracts against an open interest reading of 1
Johnson & Johnson Sees $1.1 Million Bearish Put Contract as Stock Trades Near 52-Week Highs
A single unusual options contract worth $1,105,500 in premium has surfaced in Johnson & Johnson, pointing to a notable bearish directional bet as JNJ shares trade at $231.02. The contract, a put struck at $230 expiring in June 2027, was placed with 550 contracts against an open interest reading of 172%, signaling this is fresh positioning rather than a roll or hedge on existing exposure. With JNJ currently sitting near the upper end of its 52-week range of $149.04 to $251.705, this trade carries meaningful context about where one large player sees risk building.
Key Drivers of the JNJ Stock Move
- Main Catalyst: One unusual put contract was flagged today on JNJ, a PUT at the $230 strike expiring June 17, 2027, with 550 contracts traded, $1,105,500 in total premium, and an open interest reading of 172%, confirming this is a new position opened above existing open interest levels.
- Bull Case: JNJ shares are up 0.72% on the session and trading at $231.02, well above the 52-week low of $149.04. The put is only modestly in the money relative to current price, and with over 13 months until expiration, the contract could easily decay without triggering if the stock holds its current level or continues higher toward the 52-week high of $251.705.
- Bear Case: The 172% open interest reading is a strong signal that this is fresh directional money, not a hedge layered onto an existing long. At $1,105,500 in premium committed to a single put position, this represents a meaningful bet that JNJ will trade below $230 at some point before June 2027, which is only about 1% below where shares sit today.
The forward setup for JNJ deserves attention from multiple angles. The put strike at $230 is essentially at the money given today's close of $231.02, meaning the options buyer needs only a modest pullback to move this contract into profitable territory. The long-dated expiration of June 2027 gives the thesis over 13 months to play out, suggesting this is not a short-term volatility bet but a more deliberate view on JNJ's trajectory from current levels. Johnson & Johnson has navigated a wide range over the past year, swinging from a low of $149.04 all the way to a high of $251.705, and the stock's proximity to that upper end of its range may itself be part of the thesis behind this trade. Investors will want to monitor whether additional large put positions emerge at nearby strikes in the coming sessions, which could indicate growing institutional conviction around downside risk heading into the second half of 2026.
JNJ Unusual Options Activity
- Type: Put | Strike: $230 | Expiry: June 17, 2027 | Volume: 550 contracts | Open Interest: 172%
Total unusual contracts flagged: 1. Total premium involved: $1,105,500. The 172% open interest reading confirms this contract was opened as new positioning, exceeding the existing open interest at that strike and expiry.
JNJ Seasonality
May and early summer have historically been a transitional period for large-cap healthcare names, as the sector often faces rotation pressure heading into the back half of the year when growth sectors tend to attract fresh capital. A long-dated put initiated in late May with a June 2027 expiry captures the full seasonal cycle across multiple quarters.
JNJ Relative Performance
JNJ is trading at $231.02, up 0.72% on the session, and sits approximately 55% above its 52-week low of $149.04 while remaining about 8% below its 52-week high of $251.705. The stock's positioning near the top of its annual range places it in a technically extended zone, which may be contributing to the appeal of at-the-money put positioning for longer-duration traders watching for mean reversion.